The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Flixotide Evohaler 250 micrograms per metered dose pressurised inhalation, suspension

PCO Manufacturing Ltd.PPA0465/073/002

Main Information

Trade NameFlixotide Evohaler 250 micrograms per metered dose pressurised inhalation, suspension
Dosage FormPressurised inhalation, suspension
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/073/002

Group Information

ATC CodeR03BA Glucocorticoids
R03BA05 fluticasone


License statusAuthorised
Licence Issued07/09/2001
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorization permits the holder to parallel-distribute product marketed in Ireland under the authorization number PA1077/044/015.
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back